FDA alerts providers to lack of sterility in NuVision Pharmacy products

Share this article:

The Food and Drug Administration expanded an alert about NuVision Pharmacy of Dallas, TX, on Saturday. It said investigators found poor sterile production practices that raised concern about a lack of sterility assurance for the company's sterile drug products.

NuVision recalled methylcobalamin injection (a form of Vitamin B12 injection) and lyophilized injection (freeze-dried powder) products in April because of a lack of sterility assurance and problems with quality control processes. Microbial contamination in a drug product can put a patient or resident at a serious infection risk, the FDA said.

Healthcare providers should check their medical supplies for NuVision sterile products, quarantine them and not give them to patients or residents, the FDA warned. Providers and consumers should report adverse reactions or problems to MedWatch

Share this article:
close

Next Article in Products

More in Products

Bertlesmann buys Relias Learning

Bertelsmann, a media company based in Germany, said last week it is buying Relias Learning from its current owners, Vista Equity Partners and LLR Partners.

Acuity Brands introduces LED collection

Acuity Brands introduces LED collection

Acuity Brands says its new CanoeTM LED Pendant and Sconce Collection from Winona Lighting® can meet the needs of designers in unique spaces.

SwimEx debuts Triton Pool

SwimEx debuts Triton Pool

SwimEx Inc. has announced the Triton, the newest member of its line of fitness and therapy pools. It is available for the commercial and residential markets.